Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Genetics and epigenetics

Diagnostics Genetics and epigenetics

Sequencing Access for All

| Liv Gaskill

An affordable genome sequencing pipeline could help low- and middle-income countries control future epidemics

Diagnostics Genetics and epigenetics

Enhance your analysis of FFPE tumor samples

| Sponsored by 10x Genomics

Pathologist annotation meets next-generation molecular profiling with Visium Spatial Gene Expression

Diagnostics Genetics and epigenetics

Redefining Diagnostic Reference Standards

| Sponsored by Horizon

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Inside the Lab Digital and computational pathology

Defining the Next Generation of NGS

| Sponsored by Thermo Fisher Scientific

Overcoming challenges of the typical NGS workflow with the Ion Torrent Genexus System

Inside the Lab Quality assurance and quality control

Large-Scale Sample Quality Control of Genomic DNA

| Sponsored by Agilent

How a Biobank Ensured Quality for a Large-Scale Study

Diagnostics Microscopy and imaging

Plan Your Spatial Profiling Experiments

| Sponsored by 10x Genomics

Questions to consider when exploring the potential of spatial transcriptomics

Diagnostics Genetics and epigenetics

Diversity in DNA

| Liv Gaskill

Insight into the association between DNA methylation and coronary heart disease across genetic populations

Diagnostics Genetics and epigenetics

The O Advantage

| Liv Gaskill

Genetic testing of ABO genotypes can reveal a person’s risk of cardiovascular disease

Subspecialties Genetics and epigenetics

Bitesized Breakthroughs: Genetics Edition

| Liv Gaskill

We round up the latest news and research in laboratory medicine – with a particular focus on genetics

Diagnostics Genetics and epigenetics

CRISPR/Cas9 That’s Out of This World

| Liv Gaskill

A CRISPR/Cas9 genome editing tool has been developed for testing DNA damage entirely in space

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register